Woof
I’m on record for posting on numerous occasions that Vivitrol, the alcohol-addiction drug from ALKS and CEPH, would be a dog.
Well, it turns out that Vivitrol is a dog. Today, ALKS lowered the Vivitrol sales guidance for the fiscal year ending 3/31/07; the new guidance for cumulative fiscal-year sales is $5-10M.
At this rate, Vivitrol will not even outsell NTMD’s BiDil.
Morale: Trying to treat people who don’t badly want to be treated is a not a great business idea.
Market Data 
Markets 
AI
